Sergio E. Baranzini, PhD, a scientist at the University of California, San Francisco (UCSF), is this year’s winner of the Barancik Prize for Innovation in MS Research, awarded by the  National Multiple Sclerosis Society (NMSS) for his groundbreaking discoveries in multiple sclerosis (MS). His efforts have helped…

InSilicoTrials (IST) has received this year’s Innovation Radar Prize for its efforts to harness artificial intelligence (AI) to advance clinical trials and predictive technologies that may benefit people with multiple sclerosis (MS) and other diseases. Launched in 2015 by the European Commission, the award recognizes European Union (EU)-funded…

The Multiple Sclerosis Society of Canada has granted its International Progressive MS Alliance (Alliance) Research Challenge Awards to 19 researchers for their work on progressive forms of multiple sclerosis (MS). Among them is Jennifer Gommerman, PhD, a professor at the University of Toronto, in Canada, who will use…

For a comprehensive support app developed for multiple sclerosis (MS) patients, RxMx and Roche have won the Patient Engagement Innovation Award from Medtech Breakthrough. The fourth annual awards program recognized top health and medical technology products and companies. Healthcare company RxMx and pharmaceutical company Roche collaborated to produce…

Stephen L. Hauser, MD, director of the University of California, San Francisco (UCSF)‘s Weill Institute for Neurosciences, has been awarded the 2017 Taubman Prize for Excellence in Translational Medical Research. Recognized for scientific work that challenged the way multiple sclerosis (MS) is regarded, Hauser’s discoveries have opened new therapeutic…

The French economic promotion agency Bpifrance has awarded Boston-based PathMaker Neurosystems a grant to finance the development of its MyoRegulator, a noninvasive neurotherapy technology to treat conditions linked to neural pathway disruption, including neuromotor spasticity in patients with multiple sclerosis (MS). Through the Programme d’Investissements d’Avenir (PIA-1), an investment program offered by Bpifrance, the  grant — whose…

Three researchers who discovered regulatory T-cells and their role in autoimmune diseases, such as multiple sclerosis (MS), have been awarded the Crafoord Prize by The Royal Swedish Academy of Sciences. The scientists — Shimon Sakaguchi, Fred Ramsdell, and Alexander Rudensky — are credited with advancing understanding of how the body…